The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson’s disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway-Reference-Cited by-同舟云学术

The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson’s disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway

Published:2021-01-28 Issue:4 Volume:36 Page:609-625
ISSN:0885-7490
Container-title:Metabolic Brain Disease
language:en
Short-container-title:Metab Brain Dis

Author:

Kambey Piniel Alphayo,Chengcheng Ma,Xiaoxiao Guo,Abdulrahman Ayanlaja Abiola,Kanwore Kouminin,Nadeem Iqra,Jiao Wu,Gao Dianshuai^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Biochemistry

Link

http://link.springer.com/content/pdf/10.1007/s11011-021-00670-2.pdf

Reference66 articles.

1. Aguiar AS Jr, Moreira EL, Hoeller AA, Oliveira PA, Cordova FM, Glaser V et al (2013) Exercise attenuates levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned mice. Neuroscience 243:46–53. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23558088. https://doi.org/10.1016/j.neuroscience.2013.03.039

2. Aoi M, Date I, Tomita S, Ohmoto T (2000a) The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Neurosci Res 36(4):319–325. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10771110. https://doi.org/10.1016/s0168-0102(00)00097-3

3. Aoi M, Date I, Tomita S, Ohmoto T (2000b) Single or continuous injection of glial cell line-derived neurotrophic factor in the striatum induces recovery of the nigrostriatal dopaminergic system. Neurol Res 22(8):832–836. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11149247. https://doi.org/10.1080/01616412.2000.11740761

4. Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M et al (2015) Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Prog Neurobiol 132:96–168. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26209473. https://doi.org/10.1016/j.pneurobio.2015.07.002

5. Bohush A, Niewiadomska G, Filipek A (2018). Role of mitogen activated protein kinase signaling in Parkinson's disease. Int J Mol Sci, 19(10). Retrieved from ://WOS:000448951000128. https://doi.org/10.3390/ijms19102973

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of Parkinson's disease with insights into screening models;Bulletin of the National Research Centre;2023-05-23

2. Amphiregulin blockade decreases the levodopa‐induced dyskinesia in a 6‐hydroxydopamine Parkinson's disease mouse model;CNS Neuroscience & Therapeutics;2023-04-26

3. Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect;Neural Regeneration Research;2023

4. Neuroprotective effects of a lead compound from coral via modulation of the orphan nuclear receptor Nurr1;CNS Neuroscience & Therapeutics;2022-11-23

5. Nurr1 Is Not an Essential Regulator of BDNF in Mouse Cortical Neurons;International Journal of Molecular Sciences;2022-06-20